Havrix 720 Junior Monodose Vaccine

Havrix 720 Junior Monodose Vaccine belongs to the class of medication called 'biologics vaccines' or 'immunising agents' used to prevent hepatitis A infection. It is given before exposure to the hepatitis A virus or shortly after (within two weeks). Hepatitis A is a vaccine-preventable liver infection caused by the hepatitis A virus (HAV) spread by contaminated food or water and contact with infected persons.

Havrix 720 Junior Monodose Vaccine contains Hepatitis A antigen virus (Inactivated). It aids in the development of immunity by producing antibodies, which are proteins that protect against infection induced by viruses in the vaccine. A booster dose must be taken at the doctor's discretion for long-term protection.

Havrix 720 Junior Monodose Vaccine should be given by a trained healthcare professional. Havrix 720 Junior Monodose Vaccine may cause side effects such as pain and discomfort at the injection site, nausea and low-grade fever. These side effects are usually mild and temporary. However, if these side effects persist or worsen, inform your doctor immediately.

Let your doctor know before taking this vaccine if you are allergic or known to hypersensitivity to a component of the vaccine or any other products. Havrix 720 Junior Monodose Vaccine will not be administered to patients with an acute febrile illness. Let your doctor know if you are you are pregnant or breastfeeding. The vaccine should not be administered to pregnant and breastfeeding women unless absolutely essential. Havrix 720 Junior Monodose Vaccine can be given to children and elderly patients. However, dosage adjustments are necessary. Havrix 720 Junior Monodose Vaccine may not interact with alcohol. Havrix 720 Junior Monodose Vaccine may not affect your ability to drive.

Havrix 720 Junior Monodose Vaccine contains ‘Hepatitis A antigen virus (Inactivated)’, which can effectively prevent hepatitis A infection if given within two weeks post-exposure. Its use is recommended for children aged less than 12 months, people who are allergic to the vaccine or vaccine component or decreased response to the vaccine, who are travelling to an area where hepatitis A is endemic (prevalent in that region), who have weak immune systems such as with HIV, and who are at risk of long-term conditions of the liver such as hepatitis B or C infection. It helps to prevent infection in the household or other close contacts such as a person living in the same household as the infected patient, a person who had sexual contact with the infected person, child-care staff or a person who is taking care of an infected child, healthcare professionals administering injections to the infected person and persons living in long-stay care facilities which are sharing toilets or other facilities with the infected person.

Let your doctor know before taking this vaccine if you are allergic or known to hypersensitivity to a component of the vaccine or any other products. Havrix 720 Junior Monodose Vaccine will not be administered to patients with an acute febrile illness. Let your doctor know if you are you are pregnant or breastfeeding. The vaccine should not be administered to pregnant and breastfeeding women unless essential. Havrix 720 Junior Monodose Vaccine can be given to children and elderly patients. However, dosage adjustments are necessary. Havrix 720 Junior Monodose Vaccine may not interact with alcohol. However, as a precautionary measure, it is advisable not to take or limit alcohol. Besides, inform your doctor if you had recently or plan to get vaccinated, especially MMR and varicella vaccines, as Havrix 720 Junior Monodose Vaccine can make these vaccines less effective. Also, do not take live vaccines within three months after taking Havrix 720 Junior Monodose Vaccine . Inform your doctor even if you feel unwell after taking Havrix 720 Junior Monodose Vaccine .

• Inform your doctor if you have blood tests after taking Havrix 720 Junior Monodose Vaccine , as this medicine may alter the results of the blood test.